Johnson & Johnson Innovation

JJDC finds transformative ideas and helps them mature into potential solutions for today’s patients. Guided by a clear, consistent investment strategy aligned with the scientific goals of Johnson & Johnson, JJDC works hand-in-hand with partners to help navigate the path to creating breakthrough health innovations. We invest across sectors—pharmaceuticals and medtech—and at all stages, from new company creation and seed-level startups to Series A and beyond, including private investments in public equity (PIPEs). All of our portfolio companies receive the same unwavering commitment to drive science and technology towards translation for patient benefit. We take a long-term approach, deploying the full capabilities of Johnson & Johnson, including discovery, clinical development, regulatory affairs, manufacturing and commercialization. Our team includes leaders in the healthcare and technology communities, many with deep R&D experience. This gives us the ability to understand our partners and provide the help they need. Every opportunity is unique, with tailored roles and terms that provide the best path to potential success.